Current status:
Cancelled Post Market
Current status date:
2002-07-31
DIN:
02239195
Electronic product monograph is not available
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Anatomical Therapeutic Chemical (ATC):
See footnote 4
J07AX OTHER BACTERIAL VACCINES
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
LIPOPROTEIN - OSPA ANTIGEN RECOMBINANT
|
30 MCG / 0.5 ML
|